What Can I Eat During Lu-177 DOTATATE Treatment for My Midgut Neuroendocrine Tumor — and Can Diet Help My Treatment Work Better

Why Food Choices Matter During Lu-177 DOTATATE Treatment

If you have a midgut neuroendocrine tumor (NET) and are receiving Lu-177 DOTATATE — also called peptide receptor radionuclide therapy, or PRRT — you may have heard that diet does not play much of a role in radiation-based treatments. For many cancer types, that may be partly true. But midgut NETs are different.

Tumors that begin in the small intestine or early colon often produce hormones that change how your body absorbs and uses food. At the same time, PRRT can cause side effects like nausea, fatigue, and diarrhea that make eating harder. Knowing what to eat and what to avoid during and between each treatment cycle can help you stay stronger throughout the process.

This guide covers the food-related challenges specific to midgut NET and Lu-177 DOTATATE. It also explains what the current evidence suggests about whether diet might support how well your treatment works.

The Nutritional Reality of Midgut NETs

Midgut NETs often produce hormones — most commonly serotonin. When the tumor releases large amounts of serotonin and related chemicals into the bloodstream, it can cause what is known as carcinoid syndrome: flushing, diarrhea, cramping, and sometimes wheezing. These hormonal effects create uncomfortable symptoms and interfere with how your body processes and absorbs nutrients from food.

According to the Neuroendocrine Tumor Research Foundation (NETRF), many NET patients report having to change their diet because of disease-related symptoms — and those changes matter even more during active PRRT treatment.

There is also a specific metabolic issue worth understanding. Your body uses the amino acid tryptophan to make several important molecules, including niacin (vitamin B3). In midgut NETs, the tumor diverts a large share of dietary tryptophan to produce serotonin instead. That leaves less tryptophan available for niacin. Over time, this can cause a niacin deficiency — and in some cases, a condition called pellagra, which involves skin changes, diarrhea, confusion, and weakness. The Carcinoid Cancer Foundation recognizes this as a well-established nutritional concern in midgut NET patients. Your care team should check your niacin status and discuss whether supplementation is right for your situation.

What Happens on Infusion Day — and How Food Fits In

On the day of your Lu-177 DOTATATE infusion, your treatment includes more than the radioactive compound. Most centers give patients an IV infusion of two amino acids — lysine and arginine — at the same time. This step is done specifically to protect your kidneys.

The kidneys naturally absorb some of the Lu-177 DOTATATE as it circulates in the body. Lysine and arginine compete with the radioactive compound for the same kidney receptors, which reduces how much radiation the kidneys receive. This protective step is standard in PRRT programs worldwide.

However, this amino acid infusion commonly causes nausea and vomiting. It is one of the most predictable side effects on treatment days. Your care team will typically give anti-nausea medications to help. It is still worth planning your meals around this. Most programs advise eating a light, bland meal a few hours before arriving, avoiding both an empty stomach and a heavy meal.

If you want a full walkthrough of what to expect on treatment day, our guide on preparing for your first Lu-177 DOTATATE infusion covers the full process step by step.

Foods and Drinks That May Trigger Symptoms

If your midgut NET causes carcinoid syndrome, certain foods and drinks can trigger flushing, diarrhea, or cramping. Managing these triggers is important at any time, but especially during PRRT when your body is under stress.

Based on dietary guidance from the Carcinoid Cancer Foundation, the following are commonly reported symptom triggers for NET patients:

• Alcohol — one of the most consistent flushing triggers. Most NET specialists advise avoiding it entirely during active treatment.
• Aged and hard cheeses — cheddar, camembert, stilton, and similar varieties are high in tyramine and biogenic amines that may provoke flushing and other symptoms.
• Cured and processed meats — sausages, salami, and deli meats are also high in amines and have been commonly linked to symptom flares.
• Certain nuts — walnuts, peanuts, Brazil nuts, and coconuts have been reported as triggers in some patients.
• Spicy foods — can worsen flushing and diarrhea in patients with active carcinoid syndrome.
• Very large meals — eating a large amount at one sitting can stimulate hormone release. Smaller, more frequent meals are generally better tolerated.
• High-fat meals — can worsen diarrhea and fat malabsorption in some patients with midgut disease.
• Large amounts of caffeine — may trigger flushing in some patients, though individual responses vary.

Triggers vary from person to person. Keeping a simple food-and-symptom diary — even brief notes after meals — can help you spot your own patterns and share useful information with your dietitian and oncology team.

Key Nutrients That Often Run Low in Midgut NET Patients

Because the tumor affects how your body digests and absorbs food, certain nutritional deficiencies are more common in midgut NET patients than in the general population. A comprehensive review published in the journal Nutrients found that patients with NETs — particularly those with disease in the small intestine — are at increased risk for deficiencies in niacin, fat-soluble vitamins (A, D, E, and K), vitamin B12, and iron.

The nutrients most worth monitoring during PRRT include:

• Niacin (vitamin B3) — Serotonin-producing tumors divert tryptophan away from niacin production. Some patients may benefit from supplementation, but only under medical supervision and at the correct dose. Too much niacin taken at once can cause its own flushing reaction, which may be mistaken for carcinoid flushing.
• Vitamin D — Deficiency is common in midgut NET patients, particularly those spending less time outdoors during treatment. Low vitamin D can affect bone health and immune function over time.
• Vitamin B12 — Patients who have had surgery to remove part of the ileum — the end section of the small intestine, where B12 is absorbed — may develop B12 deficiency. This can cause fatigue, nerve symptoms, and anemia.
• Iron — Poor absorption or chronic blood loss can lead to iron-deficiency anemia, which may significantly worsen treatment-related fatigue.
• Protein — Cancer and its treatment both increase your need for protein. Ongoing diarrhea or malabsorption may mean you aren't absorbing enough protein from food alone.

Ask your care team to include nutritional blood markers in your routine monitoring schedule. Catching these deficiencies early may help you tolerate treatment better and recover more easily between cycles.

Building a Midgut NET-Friendly Eating Pattern

Rather than focusing only on what to avoid, think about creating a foundation of foods that are easy to digest and rich in nutrients. The NETRF offers several practical strategies that many NET patients find helpful during treatment:

• Eat small meals often — five or six smaller meals through the day help reduce hormone triggers and aid digestion, rather than three large ones.
• Prioritize lean protein — chicken, turkey, fish, eggs, and low-fat dairy tend to be well tolerated and help meet higher protein needs during treatment. Including adequate tryptophan from these protein sources may also support niacin levels.
• Choose cooked vegetables over raw — raw vegetables can be hard to digest when diarrhea is active. Steamed or roasted vegetables are generally easier while still providing important nutrients.
• Go easy on fiber when symptoms are flaring — white rice, plain pasta, and toast may be easier to manage on high-diarrhea days. When symptoms are more controlled, whole grains offer better long-term nutrition.
• Stay well hydrated — diarrhea causes significant fluid and electrolyte loss. Water, low-sodium broth, and oral rehydration drinks help restore what you lose. Good hydration is especially important in the first 48 hours after each infusion.
• Keep a food-and-symptom diary — brief notes about what you ate and how you felt afterward help your dietitian match recommendations to your needs.

Hydration After Each Treatment Cycle

In the day or two following each infusion, your care team will ask you to drink plenty of fluids and urinate frequently. This is about radiation safety, not general wellness. Flushing the urinary system helps reduce how long any unbound radioactive material stays in contact with the kidneys and bladder lining.

Most programs recommend drinking two to three liters of water or other fluids in the first 24 hours after each infusion. Water is the best choice. Avoid alcohol during this period. If nausea makes drinking difficult, try small sips taken frequently rather than large amounts at once. Cold or room-temperature fluids often sit better than hot drinks in the hours immediately following treatment.

Can Diet Actually Help Your Treatment Work Better?

This is one of the most common questions patients ask — and it deserves an honest, nuanced answer.

There is not yet strong direct evidence that specific foods make Lu-177 DOTATATE more effective at targeting tumor cells. The treatment works by binding to somatostatin receptors on the tumor surface and delivering targeted radiation from within the cell. That mechanism is not directly driven by what you eat.

However, diet may support treatment indirectly in a few ways. First, good nutritional status before and during treatment may help your body handle side effects better. Research across multiple cancer types suggests that patients with significant malnutrition or muscle loss before treatment have more side effects and recover more slowly. Maintaining your weight and nutritional markers is a form of preparation that matters clinically.

Second, managing carcinoid syndrome symptoms through food choices can help prevent unnecessary dehydration and electrolyte imbalance — both of which can prevent you from finishing all four planned PRRT cycles on schedule. Completing the full course as planned is important for outcomes.

Third, there is growing research interest in the relationship between diet, gut health, and immune function in people with cancer. Some evidence suggests that Mediterranean-style eating patterns may broadly support immune health. However, this research is not yet specific enough to PRRT to translate into firm recommendations for midgut NET patients. The most grounded statement remains: a diet that controls your symptoms and keeps your weight stable is one that helps you stay on track with treatment — and that has real clinical value.

Supplements and Herbal Products — A Cautious Approach

Many patients consider adding vitamins, supplements, or herbal products alongside their cancer treatment. It is important to discuss every supplement with your oncologist and nuclear medicine team before starting anything new.

Lu-177 DOTATATE works by binding to somatostatin receptors on the tumor surface. Some compounds may theoretically affect receptor expression or the tumor's uptake of the radioactive compound, though evidence remains limited in this area. The general principle is caution until your care team has reviewed what you are considering.

High-dose antioxidant supplements — such as very large doses of vitamin C or vitamin E — are often flagged during radiation-based therapies. Radiation works partly by generating reactive oxygen species that damage tumor cells. Very high antioxidant intake might theoretically reduce this effect, though the evidence for PRRT isn't clear. As a precaution, most oncology teams advise against very high-dose antioxidant supplements during active treatment cycles. Dietary amounts from whole foods are not a concern.

Fatigue is a common challenge during PRRT cycles, and what you eat plays a role in energy levels. Our article on managing fatigue during Lu-177 DOTATATE therapy covers both dietary and lifestyle approaches that may help with energy between infusions.

Working With a Specialist Dietitian

Nutrition for midgut NET patients is complex enough to need a dietitian who understands neuroendocrine tumors specifically. General cancer nutrition guidance doesn't always work for NET patients — particularly those with carcinoid syndrome, chronic diarrhea, fat malabsorption, or a history of bowel surgery involving the ileum.

Ask your oncology team for a referral to a registered dietitian with experience in gastrointestinal or NET oncology. Many centers that offer PRRT have dietitians familiar with GEP-NET nutrition. If yours does not, the NETRF and the Carcinoid Cancer Foundation both offer patient-facing nutrition resources that can help you have better conversations with your care team.

For a complete look at side effects during PRRT and evidence-based ways to manage them, the guide on what side effects to expect from Lu-177 DOTATATE and how to manage them covers treatment-related symptoms and ways to handle them.

When to Talk to Your Doctor

Contact your oncologist or care team promptly if you notice any of the following during or between Lu-177 DOTATATE treatment cycles:

• Unintended weight loss of more than a few pounds between cycles
• Persistent nausea or vomiting that stops you from eating or drinking for more than 24 hours
• Diarrhea that is frequent, watery, or not responding to your usual medications
• Significant fatigue that may suggest anemia or a nutritional deficiency
• New skin changes, confusion, or other symptoms that could point to a nutritional problem such as niacin deficiency
• Any questions about a supplement, vitamin, or herbal product you are considering starting

Your care team can order the right blood tests, check for deficiencies, and adjust your nutrition support accordingly. Eating well during PRRT is not minor — it helps you stay strong enough to complete your full course of treatment and recover well between cycles.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.